Filing Details
- Accession Number:
- 0001104659-21-054478
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-23 16:30:39
- Reporting Period:
- 2021-04-21
- Accepted Time:
- 2021-04-23 16:30:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1760542 | Hookipa Pharma Inc. | HOOK | () | XX |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1441261 | Fcpr Vi Capital Sofinnova | C/O Hookipa Pharma Inc., 350 Fifth Avenue, 72Nd Floor, Suite 7240 New York, NY 10118 | No | No | Yes | No | |
| 1574139 | Sas Partners Sofinnova | C/O Hookipa Pharma Inc., 350 Fifth Avenue, 72Nd Floor, Suite 7240 New York, NY 10118 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-21 | 328,620 | $11.60 | 3,177,574 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.
Billionaire Hedge Funds
